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Clin ica l manifestations of hepatic damage in thyrotoxicosis are rearely 
observed. Nevertheless, functional, biochemical and pathoanatomical studies 
of the liver show that overactivity of the thyroid gland leads to considerable 
disorders in its functions ( 1 , 2 , 3 , 4 , 7 ,8 , 11, 16). The metabolism of lipids in the 
liver is disturbed (10, 17), the glycogen content of hepatocytes (5) and of adeno­
sine З ' -phospha te as well (2) is reduced, whilst the content of serum-glutamic 
oxalacetic transaminase (aspartate-aminotransferase) (13), a lkal ine and acid 
phosphatase (12) is increased. I t is supposed that the listed changes are due 
to the effect exerted by thyroid hormones on mitochondria (12). 
Paral lel to changes in the content of some enzymes wi th in the hepatic 
tissue, changes in th»ir serum level are also established (9, 12). Kuback i et al 
(cited by 12) state that the increase in serum alkaline phosphatase is due to 
the latter's rise in the tissues, and to the modified tissues to serum transport. 
L i v e r ferments and their changes in the serum of thyrotoxicosis patients are 
s t i l l insufficiently studied (7). 
The dynamics of hepatic changes in thyrotoxicosis under the influence of 
thyrostatic therapy is likewise scarcely explored. Actua l ly , the most widely 
employed thyrostatics — mercaptoimidazoles — rank first in the list of hepa-
totoxic drugs (6), while experimental studies by M . Oprescu et al (1974) have 
demonstrated their hepatoprotective action. 
We made it our aim to study the changes in the functional state of. l iver 
in patients affected wi th thyrotoxicosis prior to and in the course of treatment 
wi th thymidazole (l-methyl-2-mercaptoimidazole). 
Material and Method 
A series of twenty patients wi th recently discovered thyrotoxicosis of 
medium-heavy degree were subjected to study. Diagnosis was established on 
the basis of cl inical picture, radioactive iodine intake by the thyroid, and 
protein-bound iodine level in the serum. A hepatic affection in the past history 
was recorded in none of the patients. 
To assay the functional state of the l iver the Bromsulphalein test was 
investigated as well as the enzymes: serum glutamic-oxalacetic transaminase 
( S G O T ) , serum glutamic-pyruvic transaminase ( S G P T ) , leucine aminopepti-
dase ( L A P ) , aldolase and alkal ine phosphatase in the serum. Enzyme studies 
were made wi th the Boehringer f i rm tests. 
ThymMaztole treatment of the patients was carried out according to a 
cdmmon scheme wi th slight ind iv idua l variat ions. I n i t i a l l y , 40—60 mg daily 
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were given, and within twenty days of the beginning of treatment, the dose-
was reduced to 30 mg, and maintained t i l l the end of the second month. There 
after, the treatment proceeded wi th a supporting dose of 10—15mgby the 
end of the 12th month. The patients were investigated befcre the beginning of 
therapy, and at the end of the 2nd and 12th month. 
Results 
The results of our studies are submitted in -Table 1 and 2. The Bromsul-
phalein test (sodium sulfobromphthalein test) which was positive in eighteen 
T a b l e 1 
Number of Patients with Pathological Bromsulphalein Test Values and Increased 
Level of Some Serum Enzymes 
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T a b l e 2 
Mean Values of Brosulphalein Test and Some Enzymes in the Serum of Patients with 
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patients prior to treatment was the one y ie ld ing pathological results most, 
frequently. W i t h i n two months of treatment, it was s t i l l positive in most af the 
patient^ aMtiough in a lower degree. The one-year-long, treatment J a i l e d 
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to ; bring about normalization of this particular test in practically half of the 
patients.-
_ . Of the enzymes studied L A P was increased most frequently. Alka l ine 
phosphatase and aldolase were increased rather rarely, whilst both transaminases 
were almpst invar iably wi th in normal l imi ts . I n the course of treatment, the 
number of patients wi th augmented enzymes in the serum decreased, whi le 
.the mean values of the Bromsulphalein test, L A P and aldolase displayed a 
regular f a l l . A lka l ine phosphatase was an exception since on the second month 
i t increased in a greater number of patients, and its mean value showed a re-
liable increase, exceeding the pre-treatment level . However, at the end of 
the 12 th month, it fell below the starting level s imilar ly to the other enzymes. 
S G O T and S G P T did not undergo noteworthy changes in the course of thymi-
dazole treatment. ; 
Discussion 
Our results demonstrate the high incidence of hepatic lesion in thyroto-
xicosis. The Bromsulphalein test which reflects the overall functional s tate 
of the l iver , and proves to be pathologically altered in vi r tual ly a l l patients', 
is par t icular ly indicative. The studied enzymes show a rise in the serum much 
more rarely, and could hardly serve as a routine test in the assessment of hepa tic 
damage in thyrotoxicosis. The possibility of enzyme increase in the serum as 
the result of damage to other organs and tissues should be by no means over-
looked. L A P rise is noted in lesion of the pancreas, increased aldolase — in 
muscular dystrophy such as thyrotoxic myopathy, and increased alkaline ph os-
phatase — in enhanced ac t iv i ty of osteoblasts (14). Nevertheless, the combined 
increase of these enzymes in the serum in conjunction wi th the pathological 
Bromsulphalein test render most verisimilar the hypothesis about the hepatic 
origin of their rise. 
Adequate thyrostatic treatment according to the scheme outlined above 
leads to a gradual lowering and normalization of the pathological Bromsul-
phalein test, and of the elevated serum enzymes as we l l . A t the end of the sec-
ond month when the patients are already c l in ica l ly euthyroid, but the thymi-
dazole dosage is s t i l l high, a judgement wi th a certain degree of reservation 
could be made about its medicamentous effect on the hepatic function. Our 
results show that both Bromsulphalein test and enzymes, except for 
alkaline phosphatase, are improved already at this early stage. Hence, the 
assumption is warranted that thymidazole at the doses employed does not 
interfere wi th the hepatic function in thyrotoxicosis patients. 
A lka l i ne phosphatase rise at the end of the second month of treatment 
might be art expression of a discrete, drug-induced hepatic lesion, e. g. intra-
hepatic cholestasis. A n y w a y , the latter conjecture is less l ikely because of the 
improvement recorded in a l l the other indicators, and the lack of c l in ical ma-
nifestations pointing to an eventual cholestasis. We feel that the explanation 
of the transitory increase in alkaline phosphatase should be sought for in the 
restorative processes, occurring in the convalescence of the disease. I t is a well 
known fact that in thyrotoxicosis a great amount of calcium is eliminated v ia 
urine wi th ensuing osteoporosis. I n the recovery period, a restoration of the 
calcium content in bones is begun, most l ike ly in connexion wi th the en-
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hanced osteoblastic ac t iv i ty . The enhanced act iv i ty of osteoblasts augments 
the level of alkal ine phosphatase in the serum (14). Th is is an explanation 
requiring further verification. 
A t the end of the 12-month-long treatment, when the doses of thymida-
zole were reduced to a minimum, and when the patients were practically per­
manently euthyroid, a substantial improvement in the functional state of 
the l iver was also established. The Bromsulphalein test was considerably re­
duced, and its mean value was closer to the uppermost normal l imi t . Enzymes 
were likewise appreciably reduced. Nevertheless, the Bromsulphalein test, 
although lowered, as compared to the starting values, was pathological in almost 
half of the patients, while L A P and alkaline phosphatase were sustained 
sl ightly augmented in sporadic cases. The reported data demonstrate that the 
reparative processes in the l iver are rather delayed, and do not run a parallel 
course to the c l in ical improvement of patients. Apparently, they are much 
slower, and the persistence of permanent hepatic lesions in isolated patients 
is by no means ruled out. There are literature reports on liver cirrhosis, devel­
oping against the background of thyrotoxicosis (3, 8) . The above facts oblige 
us to follow wi th greater attention the hepatic function of thyrotoxicosis pa­
tients covered by the outpatient network, to spare the liver during drug pres­
criptions, and to conduct hepatoprotective therapy in instances of persisting 
pathological Bromsulphalein test. 
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ИЗМЕНЕНИЯ ФУНКЦИОНАЛЬНОГО СОСТОЯНИЯ ПЕЧЕНИ 
У БОЛЬНЫХ ТИРЕОТОКСИКОЗОМ 
Д. Коев, В. Таркаева-Николова, Л. Коева, В. Сиракова 
П. Герое, Р. Дражева 
Р Е З Ю М Е 
Исследованы бромсульфалеиновая проба и энзимы: глютамат-оксал-
уксусная трансаминаза (СГОТ), глютамат-пируватная трансаминаза (СГПТ) , 
левцинаминопептидаза (ЛАП), алдолаза и щелочная фосфатаза в сыворотке 
у 20 больных тиреотоксикозом при лечении тимидазолом (1-метил-2-меркап-
тоимидазол) в течении года. Патологическая бромсульфалеиновая проба 
установлена у 18 больных, в то время к а к энзимы в сыворотке повышаются 
у значительно меньшего числа больных. В конце второго месяца лечения 
определяется тенденция к нормализации исследуемых показателей за ис­
ключением щелочной фосфатазы, уровень которой повышается . После ле­
чения в течении года тенденция к нормализации показателей еще более 
сильно выражена , но у 9 больных бромсульфалеиновая проба все еще не 
достигла границ нормы. Щелочная фосфатаза и Л А П тоже остаются повы­
шенными у отдельных больных. 
Указывают необходимость динамического наблюдения за функциональ­
ным состоянием печени при тиреотоксикозе и проведения гепатопротектив-
ного лечения у отдельных больных. 
